Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine in pediatric patients with autism spectrum disorders
NCT01592747Phase 2Completed
- Sponsor
- Forest Laboratories
- Start
- Sep 2012
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 2 trial of memantine in Autism Spectrum Disorder (ASD), sponsored by Forest Laboratories. Started Sep 2012; status: completed.
02
Drugs
memantine
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT01592747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01592747.